Related Experiment Video
Updated: May 12, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management
Allen S Ho1, Sevin Turcan, Timothy A Chan
1Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Abstract:
The emergence of epigenetic mechanisms as key regulators of gene expression has led to dramatic advances in understanding cancer biology. Driven by complex layers that include aberrant DNA methylation and histone modification, epigenetic aberrations have emerged as critical processes that disrupt cellular machinery and homeostasis. Recent discoveries have already translated into successful clinical trials and improved patient care, with several agents approved for hematologic disease and others undergoing study. As the field matures, substantial challenges persist that will require resolution. These include the need to decipher more fully the interplay between the epigenetic and genetic machinery, patient selection and improving treatment efficacy in solid tumors, and optimizing combination therapies to counteract chemoresistance and minimize adverse effects. Here, we review recent progress in epigenetic treatments and consider their implications for future cancer therapy.
Insights
Epigenetic treatments targeting DNA methylation and histone modification show promise in cancer therapy. Further research is needed to overcome challenges in solid tumors and combination therapies for improved patient outcomes.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic mechanisms like DNA methylation and histone modification are crucial regulators of gene expression in cancer.
- Aberrant epigenetic processes disrupt cellular homeostasis and contribute to cancer development.
- Epigenetic therapies have already shown success in hematologic malignancies.
Purpose of the Study:
- To review recent advancements in epigenetic treatments for cancer.
- To discuss the implications of these advancements for future cancer therapy.
- To highlight persistent challenges in the field.
Main Methods:
- Review of recent scientific literature on epigenetic cancer therapies.
- Analysis of clinical trial data and approved epigenetic agents.
- Discussion of ongoing research and future directions.
Main Results:
- Several epigenetic agents are approved for hematologic diseases, with others in clinical trials.
- Progress has been made in understanding the interplay between epigenetic and genetic factors.
- Challenges remain in patient selection and efficacy for solid tumors.
Conclusions:
- Epigenetic therapies represent a significant advancement in cancer treatment.
- Optimizing combination therapies is crucial for overcoming chemoresistance and minimizing side effects.
- Continued research is essential to fully realize the potential of epigenetic treatments in diverse cancer types.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...

